WASATCH ADVISORS LP

Holdings History for Esperion Therapeutics, Inc. - Common Stock (ESPR)

Symbol: ESPR on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 10.9M shares
Security Ownership: 5.5%

Shares, Excluding Options vs Price

Value, Excluding Options

WASATCH ADVISORS LP ownership in Esperion Therapeutics, Inc. Common Stock (ESPR)

2025-04-07 - WASATCH ADVISORS LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.9M shares of Esperion Therapeutics, Inc. Common Stock (ESPR). This represents 5.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
WASATCH ADVISORS LP	5.5%		$16.6M	10.9M			$1.52	13G/A	3/31/2025	7 Apr 2025 14:15:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.27%	+0.01%	$53.9M	24.5M	+1,136,245	+4.87%	$2.20	Q4 2024
9/30/2024	0.19%	+0.05%	$38.5M	23.3M	+6,483,070	+38.4%	$1.65	Q3 2024
6/30/2024	0.2%	+0.09%	$37.4M	16.9M	+7,733,296	+84.7%	$2.22	Q2 2024
3/31/2024	0.13%	+0%	$24.5M	9.13M	+238,544	+2.68%	$2.68	Q1 2024
12/31/2023	0.15%	-0.05%	$26.6M	8.89M	-2,634,997	-22.9%	$2.99	Q4 2023
9/30/2023	0.07%	-0.01%	$11.3M	11.5M	-1,613,456	-12.3%	$0.98	Q3 2023
6/30/2023	0.11%	0%	$18.3M	13.1M	-214,630	-1.61%	$1.39	Q2 2023
3/31/2023	0.13%	+0.06%	$21.2M	13.4M	+6,505,808	+95%	$1.59	Q1 2023
12/31/2022	0.29%	-0.03%	$42.7M	6.85M	-614,638	-8.24%	$6.23	Q4 2022
9/30/2022	0.35%	0%	$50M	7.46M	-82,992	-1.1%	$6.70	Q3 2022
6/30/2022	0.3%	-0.02%	$48M	7.55M	-601,372	-7.38%	$6.36	Q2 2022
3/31/2022	0.19%	+0.04%	$37.8M	8.15M	+1,761,117	+27.6%	$4.64	Q1 2022
12/31/2021	0.13%	+0.06%	$31.9M	6.39M	+3,111,903	+95%	$5.00	Q4 2021
9/30/2021	0.16%	-0.02%	$39.5M	3.27M	-492,575	-13.1%	$12.05	Q3 2021
6/30/2021	0.32%	-0.03%	$79.7M	3.77M	-351,150	-8.53%	$21.15	Q2 2021
3/31/2021	0.52%	+0.02%	$116M	4.12M	+120,075	+3%	$28.05	Q1 2021
12/31/2020	0.51%	+0.2%	$104M	4M	+1,588,327	+65.9%	$26.00	Q4 2020
9/30/2020	0.57%	+0.28%	$89.6M	2.41M	+1,165,257	+93.6%	$37.17	Q3 2020
6/30/2020	0.46%	+0.13%	$63.9M	1.24M	+338,090	+37.3%	$51.31	Q2 2020
3/31/2020	0.3%	+0.08%	$28.6M	906K	+241,629	+36.4%	$31.53	Q1 2020
12/31/2019	0.33%	+0.02%	$39.6M	665K	+34,310	+5.44%	$59.63	Q4 2019
9/30/2019	0.22%	0%	$23.1M	630K	-7,978	-1.25%	$36.66	Q3 2019
6/30/2019	0.29%	+0%	$29.7M	638K	+586	+0.09%	$46.52	Q2 2019
3/31/2019	0.28%	+0.03%	$25.6M	638K	+75,165	+13.4%	$40.15	Q1 2019
12/31/2018	0.34%	+0%	$25.9M	563K	+5,339	+0.96%	$46.00	Q4 2018
9/30/2018	0.28%	+0.01%	$24.7M	557K	+16,273	+3.01%	$44.37	Q3 2018
6/30/2018	0.26%	-0.02%	$21.2M	541K	-50,230	-8.5%	$39.19	Q2 2018
3/31/2018	0.55%	-0.1%	$42.8M	591K	-102,023	-14.7%	$72.33	Q1 2018
12/31/2017	0.61%	-0.02%	$45.6M	693K	-20,139	-2.82%	$65.84	Q4 2017
9/30/2017	0.49%	-0.03%	$35.8M	713K	-42,311	-5.6%	$50.12	Q3 2017
6/30/2017	0.49%	-0.01%	$35M	756K	-10,828	-1.41%	$46.28	Q2 2017
3/31/2017	0.4%	+0.12%	$27.1M	767K	+228,349	+42.4%	$35.31	Q1 2017
12/31/2016	0.1%	+0%	$6.74M	538K	+11,477	+2.18%	$12.52	Q4 2016
9/30/2016	0.11%	0%	$7.3M	527K	-7,057	-1.32%	$13.85	Q3 2016
6/30/2016	0.08%	-0.03%	$5.27M	534K	-225,409	-29.7%	$9.88	Q2 2016
3/31/2016	0.19%	+0.01%	$12.5M	759K	+43,602	+6.09%	$16.49	Q1 2016
12/31/2015	0.22%	+0.01%	$15.9M	716K	+25,208	+3.65%	$22.26	Q4 2015
9/30/2015	0.22%	0%	$16.3M	690K	-12,960	-1.84%	$23.59	Q3 2015
6/30/2015	0.63%	-0.05%	$57.5M	703K	-52,238	-6.91%	$81.76	Q2 2015
3/31/2015	0.73%	-0.24%	$70M	756K	-247,151	-24.6%	$92.60	Q1 2015
12/31/2014	0.42%	+0.18%	$40.6M	1M	+418,688	+71.7%	$40.44	Q4 2014
9/30/2014	0.15%	-0.01%	$14.3M	584K	-19,997	-3.31%	$24.46	Q3 2014
6/30/2014	0.09%	0%	$9.57M	604K	-2,533	-0.42%	$15.84	Q2 2014
3/31/2014	0.09%	0%	$9.17M	607K	-13,260	-2.14%	$15.12	Q1 2014
12/31/2013	0.08%		$8.52M	620K			$13.74	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.